Ascend Capital’s NuVasive, Inc. NUVA Stock Holding History

Ascend Capital’s Portfolio NUVA Stock Details NUVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-183,218	Closed	-$13.7M	–	192
2017 Q1	$13.7M	Buy	+183,218	New	+$13.3M	0.62%	62

Other funds holding NUVA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VOYA Investment Management Atlanta, Georgia $96.1B AUM 40.06% 1-Year Est. Return

Jana Partners New York $1.34B AUM 4.95% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Ascend Capital's NUVA Position: Q2 2017 in Review

Ascend Capital sold out of NuVasive, Inc. (NUVA) in Q2 2017, closing a stake of 183,218 shares — an estimated $13.7M sold.

Ascend Capital first reported a position in NUVA in Q1 2017 and held it in 1 quarter. The position peaked at $13.7M in Q1 2017. 298 funds tracked by Wall St. Rank hold NUVA as of Q2 2017.

Ascend Capital reported no remaining NuVasive, Inc. position as of Q2 2017 after selling out during the quarter.
Ascend Capital sold 183,218 NuVasive, Inc. shares in Q2 2017, an estimated $13.7M.
Ascend Capital first reported a position in NuVasive, Inc. in Q1 2017 and held it in 1 quarter.
Ascend Capital's NuVasive, Inc. position peaked at $13.7M in Q1 2017.
298 funds tracked by Wall St. Rank held NuVasive, Inc. as of Q2 2017.

Based on Ascend Capital's 13F filing for Q2 2017, filed 11 Aug 2017.